139 related articles for article (PubMed ID: 34773684)
1. Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder.
Hensley PJ; Bree KK; Guo CC; Lobo N; Campbell MT; Pettaway CA; Kamat AM
BJU Int; 2022 Nov; 130(5):604-610. PubMed ID: 34773684
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report.
Nagumo Y; Maejima A; Toyoshima Y; Komiyama M; Yonemori K; Yoshida A; Fujimoto H
Int J Surg Case Rep; 2018; 48():1-4. PubMed ID: 29758320
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Myofibroblastic Tumour of the Urinary Bladder in a Middle-Aged Man-A Case Report of an Unusual Localization of a Rare Tumour.
Prijovic N; Santric V; Babic U; Stankovic B; Acimovic M; Cekerevac M; Nikolic G; Cegar B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109749
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B
Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory myofibroblastic tumour of the bladder: a case report and review of the literature.
Marais B; Eyal P; Kesner K; John J
Ther Adv Urol; 2022; 14():17562872221096385. PubMed ID: 35600997
[TBL] [Abstract][Full Text] [Related]
7. Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up.
Thomas DJ; Roberts JT; Hall RR; Reading J
BJU Int; 1999 Mar; 83(4):432-7. PubMed ID: 10210567
[TBL] [Abstract][Full Text] [Related]
8. [Two Cases of Inflammatory Myofibroblastic Tumor of the Urinary Bladder].
Ogawa K; Shimizu Y; Tsuchihashi K; Kida K; Kanamaru S; Ishihara M; Hashimoto K; Ito N
Hinyokika Kiyo; 2018 Nov; 64(11):445-450. PubMed ID: 30543744
[TBL] [Abstract][Full Text] [Related]
9. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
10. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
11. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
12. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Schöffski P; Sufliarsky J; Gelderblom H; Blay JY; Strauss SJ; Stacchiotti S; Rutkowski P; Lindner LH; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Nzokirantevye A; Collette S; Wozniak A
Lancet Respir Med; 2018 Jun; 6(6):431-441. PubMed ID: 29669701
[TBL] [Abstract][Full Text] [Related]
13. Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13].
Kamat AM
Urol Oncol; 2013 Jul; 31(5):717-8. PubMed ID: 23796202
[TBL] [Abstract][Full Text] [Related]
14. [Carcinosarcoma of the urinary bladder].
Kuntz RM; Geyer V; Savvas V; Grosse G
Urologe A; 1993 Jan; 32(1):59-63. PubMed ID: 8447047
[TBL] [Abstract][Full Text] [Related]
15. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of inflammatory myofibroblastic tumor in bladder secondary to prostate treated with laparoscopic radical cystectomy.
Zhang HH; Qi F; Zu XB; Xu L; Liu LF; Qi L
Med Sci Monit; 2012 Aug; 18(8):CS63-66. PubMed ID: 22847204
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Myofibroblastic Tumor of the Urinary Bladder: An 11-Year Retrospective Study From a Single Center.
Chen C; Huang M; He H; Wu S; Liu M; He J; Zang H; Xu R
Front Med (Lausanne); 2022; 9():831952. PubMed ID: 35308527
[TBL] [Abstract][Full Text] [Related]
18. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
19. Crizotinib in ALK
Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
[TBL] [Abstract][Full Text] [Related]
20. Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib.
Fujiki T; Sakai Y; Ikawa Y; Takenaka M; Noguchi K; Kuroda R; Abe T; Nomura K; Sakai S; Wada T
Pediatr Blood Cancer; 2023 Apr; 70(4):e30172. PubMed ID: 36635892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
